Skip to main navigation Skip to search Skip to main content

Advantages and limits of targeted radionuclide therapy with somatostatin antagonists

Elif Hindie, Clement Morgat, Paolo Zanotti-Fregonara, Magalie Haissaguerre, Laurence Bordenave, Antoine Tabarin

Research output: Contribution to journal › Letter › peer-review

3   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Advantages and limits of targeted radionuclide therapy with somatostatin antagonists'. Together they form a unique fingerprint.
Sort by